Baker Bros. Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,466,547 shares of RARE stock, worth $83.2 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
1,466,547
Previous 1,466,547
-0.0%
Holding current value
$83.2 Million
Previous $68.5 Million
11.97%
% of portfolio
0.8%
Previous 0.87%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
288Shares Held
88.1MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$318 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$304 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$259 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$185 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...